Award details

Targeted Drug Delivery to the Cornea of the Eye Via Medicated Contact Lenses and Mucoadhesive Thin Films

Reference	BB/S004874/1
Principal Investigator / Supervisor	Professor Andrew Quantock
Co-Investigators / Co-Supervisors	Dr Charles Heard, Professor David Whitaker
Institution	Cardiff University
Department	Optometry and Vision Sciences
Funding type	Research
Value (£)	511,563
Status	Completed
Type	Research Grant
Start date	01/02/2019
End date	28/12/2022
Duration	47 months

Abstract

unavailable

Summary

A healthy cornea, the clear tissue at the front of the eye, is essential for vision. If it becomes infected or diseased, however, vision can be lost. Infection can occur because of viruses, parasites, fungi or bacteria, and the problem is serious. A bacterial infection of the eye called trachoma, as one example, is the world's leading cause of preventable blindness. It is highly contagious, with around 41 million people, mostly women and children in the developing world, infected. Traditionally, eye drops containing medicines are used to treat corneal disease or infection, but this is highly inefficient because the drug is immediately diluted by tears and most of the dose is washed away within a few blinks. Our research will develop drug-loaded contact lenses and purpose-made biodegradable thin films that can be applied to the eye for the effective and controlled-release delivery of disease-specific medications to the cornea to treat a wide range of potentially blinding conditions.

Committee	Not funded via Committee
Research Topics	X – not assigned to a current Research Topic
Research Priority	X – Research Priority information not available
Research Initiative	Follow-On Fund Super (SuperFOF) [2012-2015]
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search